论文部分内容阅读
我院在体外和动物试验基础上,于1989年底开始将试验室研制的高纯度胆固醇溶剂—甲基叔丁醚(methyl tert-butyl ether,MTBE)应用于临床,经皮经肝胆囊穿刺置管灌注溶解胆固醇结石。不久,在松江泗泾医院和鹿苑医院也开展了这一工作。至1992年9月,共对95例症状性胆囊结石病人试行了经皮经肝胆囊穿刺置管,其中81例置管成功并完成了溶石或“碎石-溶石”治疗,总结如下。 1 材料与方法 1.1 病人情况症状性胆囊结石病人95例,男10例,女85例。年龄在27～66岁。病程1～15年。结石1～10枚,直径0.8～3cm。口服胆囊造影88例
Our hospital in vitro and animal experiments based on the end of 1989 began to laboratory developed high-purity cholesterol solvent - methyl tert-butyl ether (methyl tert-butyl ether, MTBE) used in clinical, percutaneous transhepatic gallbladder puncture catheter Perfusion dissolved cholesterol stones. Soon, Songjiang Sijing Hospital and Luyuan Hospital also carried out this work. To September 1992, a total of 95 patients with symptomatic gallbladder stones were tried percutaneous transhepatic gallbladder catheterization, of which 81 cases of successful catheterization and completed the dissolution of stone or “” lithotripsy - "treatment, concluded as follows. 1 Materials and Methods 1.1 The patient’s condition Symptomatic gallstone patients 95 cases, 10 males and 85 females. The age of 27 to 66 years old. Course of 1 to 15 years. 1 to 10 stones, diameter 0.8 ~ 3cm. 88 cases of oral cholecystography